Practising Law Institute: Health Care 2010: Managing Risks in the New Compliance and Enforcement Environment

Practising Law Institute: Health Care 2010: Managing Risks in the New Compliance and Enforcement Environment

Speaking Engagement
This conference, presented by PLI, will focus on the recent changes in health care law, including those that will come about as a result of the recently passed health care reform bill. Attendees will have the opportunity to hear speakers from the FDA, FTC, DOJ, OMIG, as well as in-house and outside counsel, discuss the new reform bill andrecent enforcement initiatives, including the focus on FCPA violations by pharmaceuticals, the creation of HEAT and prosecutions of executives under the FDCA. Topics to be discussed include: structuring compliant relationships with health care providers and clinical investigators; scientific discourse and promotional guidelines affecting FDA-regulated products; federal and state compliance and investigation issues, including issues arising under disclosure, false claims, anti-kickback, and Stark laws; ethical issues in advising clients in the health care industry; and health care reform developments affecting your client.

WilmerHale partner David Ogden will be a featured speaker at this event. He will speak on the topic of "Health Care Reform: Impact on Compliance and Enforcement Initiatives."

Read More About the Event

Speakers

You May Be Interested In

Health Care Privacy 101 and Beyond

September 1, 2026
Speaking Engagement

Data Subject Rights: What Happens After the Request Comes In

September 8, 2026
Speaking Engagement

2026 POWER Act Webinar for District Courts in the Ninth Circuit

September 15, 2026
Speaking Engagement
View all Events

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel